Arkolith/Insider Trading/CCCC/Form 4

Hirsch Andrew

President & CEO, DirectorC4 Therapeutics, Inc. (CCCC) · full profile →Form 4 · filed Nov 12, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2024Tax withholding(F)6K$6.04$34K222K
Nov 7, 2024Option exercise(M)13K——227K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 7, 2024Option exercise(M)13K—$035K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001662579-24-000100) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML